Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back

Haner Direskeneli, MD

Marmara University
ISTANBUL, Turkey

Haner Direskeneli, MD is a Professor of Rheumatology and is currently the Chief of the Division of Rheumatology and Department of Internal Medicine in Marmara University, School of Medicine, Istanbul, Turkey. He graduated from Istanbul University, had residency trainings in Internal Medicine/ Rheumatology in Marmara University and fellowships in Lupus Research Unit and Oral Immunology in UMDS, London UK. His main research interests are oral health and other environmental factors, epigenetics, diagnostic tools and new therapeutic approaches in Behcet's Disease and genetics, assessment, clinical course and prognosis of Takayasu's arteritis. He is a member of OMERACT large-vessel vasculitis and Behcet Study Interest Groups and is part of a EULAR taskforce for Imaging in large-vessel vasculitis. He has > 250 peer-reviewed articles.

Presentation(s):

  • 1564: Common Femoral Vein Wall Thickness Measurement as a Diagnostic Test in Suspected Behçet’s Disease

    Monday, November 13, 2023
    9:00 AM – 11:00 AM PT

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); celltrione: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Roche: Educational (Ongoing); UCB: Educational (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • 1568: Comparison of Methotrexate and Azathioprine as the First Steroid-Sparing Immunosuppressive Agent in Patients with Takayasu's Arteritis

    Monday, November 13, 2023
    9:00 AM – 11:00 AM PT

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); celltrione: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Roche: Educational (Ongoing); UCB: Educational (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Causes and Management of Oral Ulcers

    Tuesday, November 14, 2023
    8:30 AM – 8:50 AM PT

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); celltrione: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Roche: Educational (Ongoing); UCB: Educational (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)